| BioID | bio3403 |
| Name | TEZACAFTOR |
| ChEMBL ID | CHEMBL3544914 |
| Molecular Formula | C26H27F3N2O6 |
| Molecular Weight | 520.5 |
| Molecular Weight (Monoisotopic) | 520.1821 |
| Type | Small molecule |
| Max Phase | Phase 4 |
| Target ID | Tar18 |
| Target Name | Serine/threonine-protein kinase cot (COT) |
| Synonyms | TEZACAFTOR|Tezacaftor|VX-661 |
| Smiles | CC(C)(CO)c1cc2cc(NC(=O)C3(c4ccc5c(c4)OC(F)(F)O5)CC3)c(F)cc2n1C[C@@H](O)CO |
| Inchi | InChI=1S/C26H27F3N2O6/c1-24(2,13-33)22-8-14-7-18(17(27)10-19(14)31(22)11-16(34)12-32)30-23(35)25(5-6-25)15-3-4-20-21(9-15)37-26(28,29)36-20/h3-4,7-10,16,32-34H,5-6,11-13H2,1-2H3,(H,30,35)/t16-/m1/s1 |
| Inchi Key | MJUVRTYWUMPBTR-MRXNPFEDSA-N |
| Molecular Species | NEUTRAL |
| Targets | 58.0 |
| Bioactivities | 82.0 |
| Np Likeness Score | -0.94 |
| Records Key | ['TEZACAFTOR', 'VX-661', 'TEZACAFTOR', 'TEZACAFTOR', 'VX-661', 'VX-661', 'TEZACAFTOR', 'VX-661', 'TEZACAFTOR', 'VX-661', '315', 'VX-661', '41', 'VX-661', 'tezacaftor'] |
| Records Name | ['TEZACAFTOR', 'VX-661', 'TEZACAFTOR', 'TEZACAFTOR', '(R)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide', 'VX-661', 'TEZACAFTOR', 'VX-661', 'TEZACAFTOR', 'VX-661', '(R)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide', 'VX-661', 'Tezacaftor', 'Tezacaftor', 'tezacaftor'] |
| Withdrawn Flag | False |
| Orphan | 0 |